Cargando…

High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases

OBJECTIVES: The prevalence of Skeletal Related Adverse Events (SREs) in EGFR mutated non-small cell lung cancer (NSCLC) patients with bone metastases, treated with modern tyrosine kinase inhibitors (TKIs), has been scarcely investigated. MATERIALS AND METHODS: We retrospectively evaluated the data o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laganà, Marta, Gurizzan, Cristina, Roca, Elisa, Cortinovis, Diego, Signorelli, Diego, Pagani, Filippo, Bettini, Anna, Bonomi, Lucia, Rinaldi, Silvia, Berardi, Rossana, Filetti, Marco, Giusti, Raffaele, Pilotto, Sara, Milella, Michele, Intagliata, Salvatore, Baggi, Alice, Cortellini, Alessio, Soto Parra, Hector, Brighenti, Matteo, Petrelli, Fausto, Bennati, Chiara, Bidoli, Paolo, Garassino, Marina Chiara, Berruti, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689017/ https://www.ncbi.nlm.nih.gov/pubmed/33282740 http://dx.doi.org/10.3389/fonc.2020.588862

Ejemplares similares

Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis
por: Gemelli, Maria, et al.
Publicado: (2022)

Association of Steroids Use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2020)

1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic
por: Gurizzan, C., et al.
Publicado: (2020)

Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations
por: Ferrara, Roberto, et al.
Publicado: (2021)

Focus on Nivolumab in NSCLC
por: Cortinovis, Diego L., et al.
Publicado: (2016)

Maintenance therapy in NSCLC: why? To whom? Which agent?
por: Novello, Silvia, et al.
Publicado: (2011)

Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
por: Borzi, Cristina, et al.
Publicado: (2020)

Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic
por: Gurizzan, Cristina, et al.
Publicado: (2021)

Targeted therapies and immunotherapy in non-small-cell lung cancer
por: Cortinovis, D, et al.
Publicado: (2016)

Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1–2, 2021
por: Berruti, Alfredo, et al.
Publicado: (2022)

New Advances in Liquid Biopsy Technologies for Anaplastic Lymphoma Kinase (ALK)—Positive Cancer
por: Villa, Matteo, et al.
Publicado: (2021)

Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases
por: Lo Russo, Giuseppe, et al.
Publicado: (2017)

Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab
por: Banna, Giuseppe Luigi, et al.
Publicado: (2020)

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma
por: Cortinovis, Diego, et al.
Publicado: (2021)

Novel Therapeutic Options for Small Cell Lung Cancer
por: Canova, Stefania, et al.
Publicado: (2023)

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
por: Garassino, Marina Chiara, et al.
Publicado: (2020)

Patient-reported outcome measurements in post-mastectomy implant-based breast reconstruction and radiotherapy: Analysis of BREAST-Q data
por: Sala, Laura, et al.
Publicado: (2022)

Worldwide Age at Onset of Female Breast Cancer: A 25-Year Population-Based Cancer Registry Study
por: Bidoli, Ettore, et al.
Publicado: (2019)

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study
por: Cantini, Luca, et al.
Publicado: (2023)

Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
por: Bonomi, Maria, et al.
Publicado: (2011)

mTOR Cross-Talk in Cancer and Potential for Combination Therapy
por: Conciatori, Fabiana, et al.
Publicado: (2018)

Role of mTOR Signaling in Tumor Microenvironment: An Overview
por: Conciatori, Fabiana, et al.
Publicado: (2018)

Editorial: Small cell lung cancer: New drugs and strategies
por: Cortinovis, Diego L., et al.
Publicado: (2023)

Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients
por: Nichetti, Federico, et al.
Publicado: (2019)

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
por: Cortellini, Alessio, et al.
Publicado: (2021)

Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?
por: Bossi, Paolo, et al.
Publicado: (2021)

Treatment Patterns, Clinical Outcomes and Healthcare Costs of Advanced Non-Small Cell Lung Cancer: A Real-World Evaluation in Italy
por: Franchi, Matteo, et al.
Publicado: (2021)

Animal models of myasthenia gravis: utility and limitations
por: Mantegazza, Renato, et al.
Publicado: (2016)

COVID-19 musculoskeletal involvement in children
por: Giraudo, Chiara, et al.
Publicado: (2023)

Survival after the diagnosis of breast or colorectal cancer in the GAZA Strip from 2005 to 2014
por: Panato, Chiara, et al.
Publicado: (2018)

Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
por: Piro, Geny, et al.
Publicado: (2019)

Simulating crowding of urban green areas to manage access during lockdowns
por: Geneletti, Davide, et al.
Publicado: (2022)

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context
por: Moroncini, Gianluca, et al.
Publicado: (2018)

C-Arm Cone-Beam CT-Guided Transthoracic Lung Core Needle Biopsy as a Standard Diagnostic Tool: An Observational Study
por: Jaconi, Marta, et al.
Publicado: (2015)

Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study
por: Cazzaniga, M. E., et al.
Publicado: (2014)

A Functional Mathematical Model to Simulate the Single-Breath Nitrogen Washout
por: Barbini, Paolo, et al.
Publicado: (2013)

Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer
por: Broggini, Massimo, et al.
Publicado: (2013)

Risk factors for territorial spreading of SARS-CoV-2 in North-eastern Italy
por: Bidoli, Ettore, et al.
Publicado: (2022)

LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial
por: Vernieri, Claudio, et al.
Publicado: (2020)

Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study
por: Cortellini, Alessio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qdj1df58itkhl2d058r1u180ac